Drug Profile
OB 318
Alternative Names: OB-318Latest Information Update: 23 Aug 2022
Price :
$50
*
At a glance
- Originator Oneness Biotech
- Class Anti-inflammatories; Antineoplastics; Herbal medicines; Traditional Chinese medicine
- Mechanism of Action 1 Phosphatidylinositol 3 kinase inhibitors; MTOR protein inhibitors; Proto oncogene protein c-akt inhibitors; Vascular endothelial growth factor A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Liver cancer